Aspirin Use in the Atherosclerosis Risk in Communities (ARIC) Study Attenuated the Risk of Coronary Heart Disease Associated with an Apolipoprotein(a) Variant

Arteriosclerosis, Thrombosis, and Vascular Biology Annual Conference 2009 April 29–May 1, 2009 Omni Shoreham Hotel Washington, DC Sponsored by the American Heart Association Council on Arteriosclerosis, Thrombosis, and Vascular Biology. Conference Chair: Alan Daugherty, PhD, DSc, FAHA Conference Co-Chairs: Robert A. Hegele, MD, FAHA; Murray W. Huff, PhD, FAHA Conference Program Committee Timothy Hla, PhD; Larry Kraiss, MD, FAHA; Steven R. Lentz, MD, PhD, FAHA; Joseph M. Miano, PhD; Kathryn J. Moore, PhD, FAHA; Susan S. Smyth, MD, PhD, FAHA; Mary Sorci-Thomas, PhD, FAHA; Hartmut Weiler, PhD; Cuihua Zhang, MD, PhD, FAHA Conference Program Committee Liaisons Jeanine D’Armiento, MD, PhD; William P. Fay, MD, FAHA; Kathy Griendling, PhD, FAHA; John S. Parks, PhD, FAHA; Muredach P. Reilly, MB, FAHA; Lawrence L. Rudel, PhD, FAHA by gest on A uust 5, 2017 http://atvajournals.org/ D ow nladed from